The labeling provided to health professionals (but not to the general public) may contain the following additional indication:
(a) For products containing haloprogin or miconazole nitrate identified in Sec. 333.210 (a) and (c). ``For the treatment of superficial skin infections caused by yeast (Candida albicans).''
(b) [Reserved]